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Sensing mechanisms of iron–sulfur cluster
regulatory proteins elucidated using native mass
spectrometry
Jason C. Crack, * Elizabeth Gray and Nick E. Le Brun *
The ability to sense and respond to various key environmental cues is important for the survival and adap-
tability of many bacteria, including pathogens. The particular sensitivity of iron–sulfur (Fe–S) clusters is
exploited in nature, such that multiple sensor-regulator proteins, which coordinate the detection of ana-
lytes with a (in many cases) global transcriptional response, are Fe–S cluster proteins. The fragility and
sensitivity of these Fe–S clusters make studying such proteins difficult, and gaining insight of what they
sense, and how they sense it and transduce the signal to affect transcription, is a major challenge. While
mass spectrometry is very widely used in biological research, it is normally employed under denaturing con-
ditions where non-covalently attached cofactors are lost. However, mass spectrometry under conditions
where the protein retains its native structure and, thus, cofactors, is now itself a flourishing field, and the
application of such ‘native’ mass spectrometry to study metalloproteins is now relatively widespread. Here
we describe recent advances in using native MS to study Fe–S cluster proteins. Through its ability to accu-
rately measure mass changes that reflect chemistry occurring at the cluster, this approach has yielded a
remarkable richness of information that is not accessible by other, more traditional techniques.
1. Introduction
Electrospray ionization mass spectrometry (ESI-MS), coupled
with liquid chromatography (LC), is today’s method of choice
for proteomic analysis. However, proteins rarely retain their
native structure in the solvent mixtures (e.g. water/acetonitrile/
formic acid) employed in such experiments, leading to a loss
of non-covalent interactions. In the early 90s, the observation
of non-covalently bound heme in myoglobin samples
suggested ESI-MS could be used to study non-covalent
protein–cofactor interactions.1 This fledgling field of non-
denaturing ESI-MS (for a contemporary review see ref. 2) was
set to capitalise on the spectacular advances in both mass
spectrometric hardware (particularly in resolution and sensi-
tivity) through the 90s to the present day. In 2004 the term
native MS was introduced to unify the bewildering terminology
(e.g., non-denaturing, non-covalent, native spray, macro- or
supra-molecular ESI-MS) that was being used to describe
similar approaches to ESI-MS experiments.3,4 Almost two
decades later, native MS is now used for accurate mass detec-
tion of intact proteins and protein complexes, and has been
used extensively to study the dynamics of protein–protein
interactions, and interactions of proteins with drugs, nucleic
acids, sugars, lipids and metals.5–15
It is estimated that up to a half of all proteins utilise a
metal ion for structural stability and/or function.16 The great-
est diversity of functional properties is exhibited by ions of the
transition metal elements (principally first row), of which iron
is the most abundant in biology. Iron occurs in three principal
forms in life: as heme (iron coordinated within the centre of a
porphyrin macrocycle); as non-heme iron (iron coordinated
directly to proteins via amino acid side chains); and, as iron–
sulfur (Fe–S) clusters, ancient protein cofactors composed
solely of iron and inorganic sulfide, which are bound to pro-
teins via the coordination of iron by amino acid side
chains,17–19 see Fig. 1. Fe–S cluster proteins are widespread in
nature and exhibit a remarkable breadth of structural and
function diversity. Many play key roles in electron transfer,
chemical catalysis and small molecule sensing.20,21
Mass spectrometry approaches have been instrumental in
the identification and characterisation of a wide variety of
metalloproteins.26–36 Fe–S clusters have been generally less
amenable to investigation by mass spectrometry because of
their sensitivity; they are acid-labile and were invariably lost
under the mildly acidic conditions employed during early
ESI-MS investigations, with only the most robust Fe–S proteins
retaining their cluster following ionization. In one of the ear-
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liest examples, the high potential Fe–S protein (HiPIP) from
C. tepidum was found to exhibit three distinct charge states (+5
to +7), reminiscent of the new charge states observed a few
years earlier for heme containing myoglobin.1,37
Deconvolution of the HiPIP spectrum was consistent with
molecular mass of the protein complete with [4Fe–4S]
cluster.37 HiPIP proteins belong to the broader ferredoxin
family, members of which naturally display high degree of
stability at or near neutral pH. Thus, they were the obvious
choice to illustrate the potential of mass spectrometric
approaches, and to help define a set of conditions suitable for
the detection of other less robust Fe–S proteins. In most cases,
the Fe–S cluster(s) survived ionization and remained associ-
ated with the protein irrespective of whether they were [2Fe–
2S] or [4Fe–4S] cluster.38–41 Recently, native MS has been
applied to a much broader range of Fe–S proteins, enabling
the determination of cluster types, and, remarkably, the nature
of chemistry taking place at clusters, in some cases in real
time.42–52 Aspects of these advances are the focus of this
article.
2. Native MS of Fe–S proteins reveals
the type of cluster
The presence of an Fe–S cluster in purified protein samples is
most commonly assessed using UV-visible absorption spec-
troscopy, with the spectra of [4Fe–4S] and [2Fe–2S] clusters
being sufficiently distinct to give an indication of the cluster
type.53 However, additional, more definitive evidence is required
for unambiguous assignment. Recently, native MS has proved
extremely useful for determining the type of Fe–S cluster ligated
to the protein framework. In comparison to other techniques,
such as electron paramagnetic resonance (EPR), Mössbauer,
and resonance Raman spectroscopies, native MS requires sig-
nificantly less sample (≤20 µM), can simultaneously resolve all
Fe–S cluster species present in the sample, does not require a
specific oxidation state for detection, and does not typically
require isotopic enrichment.44–46,54,55
Native MS has been widely used in determining the cluster
type of members of the Rrf2 family of bacterial transcriptional
regulators, which function in sensing a wide range of environ-
mentally important cues: where characterized, members of
this family have been found to sense nitric oxide (NO)/nitrosa-
tive stress (NsrR),43,56 redox balance/oxidative stress (HypR,
SaiR, RsrR),54,57,58 cysteine availability (CymR),59 the iron–
sulfur cluster status of the cell (IscR),60–62 and iron limitation
(RirA).45,48,63,64 Members of the family can be broadly divided
according to whether or not they utilise an Fe–S cluster as the
sensory module.59,65 Here we highlight the use of native MS in
determining the type of Fe–S cluster bound to the protein
framework of three Rrf2 members: NsrR, RsrR and RirA.
2.1 [4Fe–4S] NsrR
NsrR functions as a regulator of NO-induced stress response in
many bacterial species.43,56 In some bacteria, such as E. coli
and S. typhimurium, ≥60 genes are under NsrR control, while
in others, such as Neisseria sp. and Streptomyces coelicolor, a
more compact (≤20) set of regulated genes is observed.42,66–68
However, many of the core genes controlled by NsrR function
in the detoxification of NO by converting it to non-toxic metab-
olites. The principal target in most species is the hmp gene,
which encodes a flavohaemoglobin that converts NO to nitrate
under aerobic conditions.67,69
Initial aerobic purifications of S. coelicolor NsrR resulted in
the presence of a [2Fe–2S] cluster (based on absorbance spec-
troscopy), while later anaerobic preparations resulted in
protein containing a [4Fe–4S] cluster, or occasionally a mixture
of [4Fe–4S] and [2Fe–2S] clusters.70,71 Although initially
unclear, the relationship between [4Fe–4S] NsrR and the pre-
viously reported [2Fe–2S] form was revealed by native MS to be
dependent upon the presence of protective low molecular
weight thiols added during the initial purifications.42 The
presence of these thiols (e.g. β-mercaptoethanol and other
non-physiological small thiols) under aerobic conditions pro-
moted the conversion of the native [4Fe–4S] cluster to a stabil-
ised [2Fe–2S] form. The recent high resolution X-ray structure
of NsrR confirmed the nature of the [4Fe–4S] cluster, and
revealed a unique coordination of the cluster at the interface
of the two subunits of the dimer, by three Cys residues of one
subunit and an Asp residue of the other (Fig. 1c).24
Fig. 1 Commonly found iron–sulfur cluster protein cofactors. (a) [2Fe–2S] cluster of Streptomyces venezuelae RsrR with unique coordination by
Cys (×2), His and Asp residues (PDB 6HSD22). (b) All Cys-coordinated [3Fe–4S] cluster of E. coli aconitase (PDB 1L5J23). (c) [4Fe–4S] cluster of
Streptomyces coelicolor NsrR, coordinated by Cys (3) and Asp (PDB 5N0724). Images generated using UCSF Chimera.25
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S. venezuelae RsrR was originally annotated as a putative
homolog of NsrR, but the nature of its regulon indicated that
it is involved in sensing redox balance (e.g. it regulates nmrA,
which encodes a NAD(P)-dependent transcriptional regulator
and several genes associated with mycothiol synthesis).54 In
contrast to NsrR, anaerobic preparations of RsrR were pink in
colour with a series of weak absorptions bands across the
300–600 nm region reminiscent of some [2Fe–2S] clusters with
non-Cys coordination. The mass spectrum contained peaks in
regions that corresponded to monomeric and dimeric forms of
[2Fe–2S] RsrR.54 The partial dissociation of proteins that are
dimeric in solution into monomers is a well-known phenom-
enon. This may result from a number of causes, including a
simple reflection of a solution equilibrium between the two
forms, an excess of energy applied following transfer to the gas
phase (collisional activation), or the disruption of hydrophobic
interactions that stabilise the dimer during transfer to the gas
phase.72 Whatever its origin, this has proved to be advan-
tageous because it simplifies the assignment of Fe–S species,
which could potentially be different in the two subunits of a
dimeric Fe–S protein.44,48 The nature of RsrR cluster was con-
firmed by the high resolution X-ray structure, which revealed
unique cluster coordination involving two Cys, one Glu and
one His residues, the first example of a cluster coordinated by
three different amino acid residues, and the first [2Fe–2S]
cluster characterised with Glu coordination (Fig. 1a).22
2.3 [4Fe–4S] RirA
RirA was discovered first in Rhizobium leguminosarum, the
nitrogen-fixing symbiont that induces root nodules on peas,
and is also found in several closely related genera of
α-proteobacteria, including other Rhizobia and other
α-proteobacteria, including the pathogens Bartonella, Brucella,
and Agrobacterium.63,73 It represses many genes involved in
iron homeostasis (e.g. siderophore biosynthesis, and heme
uptake) by binding to operator sequences known as “IRO
boxes”. RirA is a member of the Rrf2 family and was hypoth-
esised to be an Fe–S protein almost 15 years ago.74
Anaerobic preparations of RirA resulted in the presence of a
[4Fe–4S] cluster (based on absorbance), which had an
enhanced [3Fe–4S]1+ EPR signal following anaerobic gel fil-
tration. This behaviour suggested the cluster has a labile
fourth iron. Again, both monomeric and dimeric forms of the
protein were observed by native MS45 (Fig. 2). A dominant peak
at 17 792 Da, corresponding to [4Fe–4S] RirA, was observed in
the monomer region. Minor, well resolved peaks were observed
on the low mass side, correspond to traces of [4Fe–3S],
[3Fe–4S], [3Fe–3S], [3Fe–2S] and [2Fe–2S] cluster forms
(Fig. 2a). Homo-dimeric [4Fe–4S] RirA dominated the dimer
region of the spectrum at 35 585 Da. Dimers containing a
mixture of [3Fe–4S] and [4Fe–4S] clusters, were also observed.45
The observation of [3Fe–4S] clusters following preparation for
native MS, which involves gel filtration, was consistent with
EPR observations (Fig. 2b).45,75 The physiological significance
of [4Fe–4S] RirA was strongly supported by the demonstration
that this form of the protein binds IRO box sequences.
Exposure to low iron conditions initiates loss of iron to initially
generate a [2Fe–2S] form, which exhibits much weaker DNA-
binding affinity before degrading further to apo-RirA, which
does not bind DNA.45
3. Time-resolved native MS reveals
the sensing mechanism of regulatory
Fe–S proteins
For processes that involve changes in mass at the active site of
a protein/enzyme, mass spectrometry has the potential to
reveal precise detail of the chemistry taking place, and in some
favourable cases this can be followed in real time. Studies of
FNR and RirA, described below, illustrate the power of time-
resolved native mass spectrometry.
Fig. 2 Characterization of the RirA Fe–S cluster by native MS. Deconvoluted native MS spectrum of [4Fe–4S] RirA in the (a) monomeric and (b)
dimeric regions. See ref. 45 for further details.
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Escherichia coli and many other organisms use FNR as a sensor
of O2 levels, enabling it to switch between aerobic and anaero-
bic metabolism according to O2 availability. The Fe–S cluster
of FNR is key to the O2 sensing mechanism: in the absence of
O2, the protein binds a [4Fe–4S] cluster, is homodimeric and
binds tightly to FNR operator sequences located in FNR-con-
trolled promoter regions, either activating or repressing tran-
scription. Through a combination of, Mössbauer, EPR and
optical spectroscopies, the [4Fe–4S] cluster of E. coli FNR was
shown to undergo a [4Fe–4S] to [2Fe–2S] cluster conversion in
response to O2,
76–79 and that this involves a transient [3Fe–4S]
intermediate.80–82 The [2Fe–2S] form of FNR is monomeric and
can no longer bind DNA with high affinity.83 The cluster conver-
sion reaction provides the driving force for the conformational
change required to disrupt dimerisation/DNA binding.
The nature of the conversion process was revealed to be
more complex than originally thought with the discovery of
persulfide-ligated [2Fe–2S] clusters by resonance Raman spec-
troscopy.84 Native MS was subsequently used to investigate the
origin of these persulfide-ligated [2Fe–2S] clusters in a site-
directed variant of FNR, S24F (hereafter referred to as FNR),
that was chosen because it is spectroscopically identical to
wild type FNR, follows the sample [4Fe–4S] to [2Fe–2S] cluster
conversion, but does so significantly more slowly,44,85 thus
enabling the application of time-resolved native MS.
Under anaerobic conditions, the monomer region of the
mass spectrum featured a major peak at 29 892 Da, while a
peak at 59 796 Da dominated the dimeric region. These obser-
vations are consistent with the presence of [4Fe–4S] FNR.
Exposure to O2 resulted in the formation of a variety of
protein-bound clusters, including the previously observed
[3Fe–4S] (29 843 Da) and [2Fe–2S] (29 720 Da) forms, along
with an unexpected [3Fe–3S] cluster (29 811 Da).44 Single
(29 752 Da) and double (29 784 Da) persulfide ligated forms of
[2Fe–2S] cluster were also observed, along with persulfide
adducts of apo FNR (Fig. 3a).
Fig. 3 Native MS of [4Fe–4S] FNR and the effect of O2 exposure. (a) Deconvoluted mass spectrum of [4Fe–4S] S24F FNR before (black line) and
after exposure (18 min, red line) to dissolved O2. This resulted in the formation of a variety of protein-bound clusters including [3Fe–4S], [3Fe–3S]
and [2Fe–2S] forms. Persulfide adducts of the [2Fe–2S] cluster and apo-FNR were also observed. (b) and (c) Temporal behaviours of the [4Fe–4S]
cluster (black squares), [3Fe–4S] cluster (yellow triangles), [2Fe–2S] cluster (red diamonds) and apo FNR (white circles) forms (in b), and [2Fe–4S]
cluster form (red diamonds) in (c) after O2 exposure. Global fitting to the experimental data is shown as solid lines. See ref. 44 for further details. (d)
Proposed mechanistic scheme for the conversion of [4Fe–4S] FNR and RirA based on ESI-MS data.44,45 The initial [4Fe–4S] cluster is coordinated by
three Cys residues. The fourth ligand, illustrated in the figure as “X”, is a Cys in FNR, but unknown for RirA. Both regulators follow a common [4Fe–
4S] to [2Fe–2S] conversion pathway, via [3Fe–4S] and [3Fe–3S] clusters. The two mechanisms diverge at indicated branch points to give persulfide
ligated [2Fe–2S] clusters (FNR, red box) or other FeS cluster types (RirA, black box).
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The data also revealed the temporal behaviour for each
observed species (Fig. 3b and c). In the dimeric region, aside
from the [4Fe–4S]/[4Fe–4S] peak, only three very low intensity
peaks were observed following reaction with O2, each corres-
ponding to an FNR dimer containing at least one [3Fe–4S]
cluster. This is consistent with cluster conversion initiating the
FNR dimer to monomer transition that modulates DNA
binding.44,78 Global analysis of multiple data sets led to the devel-
opment of a model that describes the kinetic characteristics of
the main [4Fe–4S], [3Fe–4S] and [2Fe–2S] cluster species, consist-
ent with previously solution-based studies, as well as those of the
newly discovered [3Fe–3S] and persulfide-bound [2Fe–2S] forms.
This study illustrated the remarkable power of native MS to reveal
intricate mechanistic details (Fig. 3d).44
The unambiguous identification of Fe–S cluster intermedi-
ates benefits significantly from the use of heavier isotopes of
iron and/or sulfur. For the latter, 34S has been used, and
methods optimised for the specific replacement of cluster
sulfide (with protein sulfur remaining at natural abundance).
This results in a +2 Da mass shift for each sulfide, see Fig. 4.
3.2 [4Fe–4S] RirA
Under low iron conditions (induced by the iron chelator
EDTA), [4Fe–4S] RirA was found to undergo a cluster conver-
sion reaction resulting in a form with absorbance features
reminiscent of a [2Fe–2S] cluster. The initial native MS spec-
trum of RirA (Fig. 5), containing an array of well resolved Fe–S
cluster species, suggested it might be possible to follow cluster
Fig. 4 Mass shifts of Fe–S species due to 34S and/or 57Fe substitution. Deconvoluted mass spectra of natural abundance and isotopically labelled
clusters and intermediates from (a) FNR, (b) NsrR and (c) WhiD. Cluster species and isotope enrichment as indicated.44,47
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conversion of both the monomeric and dimeric forms.45
Under low iron and anaerobic conditions the [4Fe–4S] RirA
peak at 17 792 Da in the monomeric region was observed to
decay away, and new peaks corresponding to protein bound
cluster fragments, including [4Fe–3S], [3Fe–4S], [3Fe–3S], [3Fe–
2S], [3Fe–S], [2Fe–2S] and [2Fe–S] (17 586–17 762 Da) initially
increased in intensity before eventually decaying away to apo-
RirA (Fig. 5). The same set of intermediates were also observed
under aerobic conditions, but the kinetics of their formation
and loss were different; see ref. 48.
To determine the sequence of events, the temporal behav-
iour of each of species was investigated. The data showed that
the [4Fe–3S] and [3Fe–4S] species were the first intermediates
to reach their maximum abundance, consistent with them
being early intermediates in the conversion process. The
[3Fe–3S] species was the next intermediate to maximize,
followed by the [3Fe–2S] and [2Fe–2S] forms.48
Global analysis of anaerobic data indicated that the loss of
a single iron ion was the obligatory first step in the conversion
process (formation of the [4Fe–3S] cluster form was minor and
most likely resulted from damage to the cluster during ioniza-
tion). The temporal behaviour of the [3Fe–3S] species was con-
sistent with it being an intermediate on the [4Fe–4S] to [2Fe–
2S] cluster conversion pathway (Fig. 5b and c). The model also
indicates that the [3Fe–3S] species may decay to a [3Fe–2S]
species, on route to apo-RirA (in part via a [2Fe–2S] species)
(Fig. 3d, black box). While a [2Fe–S] species was observed, its
temporal behaviour could not be sensibly modelled,
suggesting that it might, at least in part, arise from the spon-
taneous re-assembly of iron/sulfide species released during the
cluster conversion process.48
The formation/decay of several intermediates was acceler-
ated in the presence of O2. However, the rate constant for the
initial [4Fe–4S] to [3Fe–4S] conversion, k = 0.32 min−1, was
independent of O2 (as found from solution studies), indicating
that the loss of and an Fe ion from the [4Fe–4S] cluster is the
rate limiting step of the conversion process.45,48 The led to the
proposal that this is the iron sensing reaction of RirA. In the
dimeric region, multiple peaks were observed primarily corres-
ponding to RirA dimers containing a pair of [4Fe–4S], [3Fe–4S],
or [2Fe–2S] cluster. The global analysis model developed for
the monomeric form of RirA was broadly applicable to the
more physiologically relevant dimeric species.48
4. Reaction of nitric oxide with Fe–S
regulatory proteins followed by native
MS
The susceptibility of Fe–S clusters to chemical reaction with
reactive nitrogen species, principally NO, is well known, and is
recognised as one of the main routes of NO toxicity.83,86 Such
reactivity has been exploited through the evolution of Fe–S
cluster regulatory proteins that control the cell’s response to
nitrosative stress. Studies of several [4Fe–4S]-containing pro-
teins revealed a rapid reaction with 8–10 NO per cluster, result-
ing in the formation of iron–nitrosyl species similar in nature
to the well characterised low molecular weight dinitrosyl iron
complexes (DNIC), Roussin’s Red Ester (RRE) and Roussin’s
Black Salt (RBS).42,43,87,88 In general, only a small proportion
of these were of the DNIC type, which can be readily detected
by EPR spectroscopy, with the majority of the RRE- and RBS-
types, which are diamagnetic and harder to characterise. Thus,
identifying the precise nature of these products, and the
mechanisms by which they are generated, has been extremely
challenging. The recent application of native MS has resulted
in significant progress in understanding mechanisms of
sensing.
4.1 [4Fe–4S] NsrR
NsrR functions as a regulator of the response to reactive nitro-
gen species (RNS), including nitric oxide (NO), in many bac-
terial species.42,68 In its [4Fe–4S] form, NsrR is able to bind
Fig. 5 Native MS of [4Fe–4S] RirA in response to low iron conditions. (a) Time dependent changes in anaerobic [4Fe–4S] RirA treated with EDTA to
simulate low iron conditions. Spectra were recorded at 0 min (black line), 4 min (grey line) and 30 min (red line) post exposure to EDTA. (b) and (c)
Temporal behaviours of the [4Fe–4S] (black squares), [3Fe–4S] (yellow triangles) (b), [3Fe–3S] (blue triangles) and [2Fe–2S] clusters (red circles) (c).
Global fitting to the experimental data is shown as solid lines. See ref. 48 for further details.
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DNA and thus repress the cell’s response to NO stress. Upon
exposure to NO, the cluster undergoes a rapid, complex, nitro-
sylation reaction resulting in the loss of DNA-binding (at ≥2
NO per cluster) and the formation of a mixture of nitrosyl
species of the DNIC, RRE and RBS.42,43,88 Recent application
of LC-ESI-MS enabled the first unambiguous identification of
NsrR-bound RRE-type species, including a persulfide-bound
form.89
Identification of intermediates of cluster nitrosylation is
particularly challenging due the rapid rate of reaction, the
transient nature of the intermediates and the spectroscopic
similarity between iron–nitrosyl species.86–88,90–93 To try to
address this, a slow NO-releasing reagent, dipropylenetriamine
(DPTA) NONOate, was chosen as the NO source for native MS
experiments. Under these conditions, NO availability limits
the reaction, enabling an in situ NO titration of samples
during native MS data acquisition.47
In the presence of NO, the peak due to [4Fe–4S] NsrR
decayed away with the concomitant formation of a new peak at
17 854 Da (+30 Da), consistent with the addition of a single NO
molecule to the [4Fe–4S] cluster (Fig. 6a). The [4Fe–4S](NO)
peak initially increased in intensity, before decaying away at
Fig. 6 Proposed mechanistic scheme for the nitrosylation of [4Fe–4S] NsrR and WhiD based on native MS data. Earliest nitrosylation intermediates
for (a) NsrR and (b) WhiD along with mass shifts due to isotopic enrichment. (c) Proposed mechanistic scheme for the nitrosylation of [4Fe–4S] NsrR
and WhiD based on ESI-MS data. Starting from the [4Fe–4S] cluster both regulators (red box, NsrR; black box, WhiD) follow the same initial path, via
mono- and dinitrosyl complexes (over lapping boxes). The two mechanisms then diverge. The NsrR cluster breaks down resulting in a loss of DNA
binding. DNIC, RRE and RBS-like species then begin to increase in abundance. For WhiD, a [4Fe–4S](NO)4 species is formed on route to an RBS-like
species. The structures illustrated here for [4Fe–4S](NO)2, [4Fe–4S](NO)4, [Fe4S3(NO)7] are speculative, and represent chemically reasonable
interpretations for the events occurring. The structure of the RBS-like species is based on other spectroscopic data. See ref. 47 for further details.
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[NO] : [4Fe–4S] ratios ≥3. A second species of NsrR, +60 Da
heavier and very likely corresponding to [4Fe–4S](NO)2, was
also observed to increase in intensity as NO was added, such
that by [NO] : [4Fe–4S] ≈ 4, it was at least as intense as the +30
Da adduct. However, an unambiguous assignment could not
be made for this +60 Da adduct, even with the use of 34S and
57Fe isotopes, due to the presence of other competing adducts
(typically Na) that obscured its detection.
A range of other iron–nitrosyl species were also detected at
higher (≥4) levels of NO. These occurred in the mass regions
that correspond to DNICs (17 588 Da, [Fe(NO)2(Cys)2]), RRE
and RBS-like protein adducts. The formation of DNICs began
almost immediately following the introduction of NO, but with
the majority of the intensity being observed at [NO] : [4Fe–4S]
ratios ≥6, indicating that DNICs are a primary product of the
nitrosylation reaction.47
In the RRE region, a persulfide coordinated species (17 736
Da, [Fe2(NO)4(S)]) increased in abundance markedly at
[NO] : [4Fe–4S] ≥ 6, reaching a maximum [NO] : [4Fe–4S] ≈ 9,
consistent with earlier LC-ESI-MS data.89 Multiple RBS-like
species were also detected with general formula [Fe4(S)3(NO)x],
where x = 3 to 6. It was noteworthy that RBS itself,
[Fe4(S)3(NO)7], was not observed,
47,94 though a putative inter-
mediate in the conversion of RRE- to RBS, [Fe4(S)2(NO)7],
was.47,95 All RRE- and RBS-like species exhibited a similar
intensity profile, increasing above [NO] : [4Fe–4S] ≥ 6,
suggesting the interconversion of RRE and RBS species, or
breakdown of higher mass nitrosyl species, see Fig. 6c.47,94
The concomitant increase in the intensity of all apo-NsrR
species at equivalent ratios suggested the protein-bound pro-
ducts of nitrosylation become unstable at high [NO] : [4Fe–4S]
ratios.47
4.2 [4Fe–4S] WhiD
In contrast to NsrR, the WhiB-like (Wbl) family of
regulators (named after the first discovered WhiB protein) are,
remarkably, found only in the actinobacteria, a phylum of
Gram-positive bacteria that includes Streptomyces, the most
abundant source of clinically important antibiotics, and
important pathogens such as Mycobacterium tuberculosis and
Corynebacterium diphtheriae. Wbl proteins are generally
small (∼10–15 kDa) and contain a highly conserved pattern
of Cys residues C(xn)C(x2)C(x5)C that will bind an Fe–S
cluster.96
In S. coelicolor, WhiB is required for the initiation of sporu-
lation septation, and WhiD is required for the late stages of
sporulation.97 In M. tuberculosis, Wbl proteins are required for
the ability of the pathogen to persist within its host for long
periods, as well as its remarkable tolerance to a wide range of
antibiotics.98 M. tuberculosis WhiB3, which is the mycobacter-
ial homologue of S. coelicolor WhiD, contributes to virulence
and is induced in mouse lungs and macrophages. It regulates
lipid and polyketide biosynthesis, including tri-acylglycerol
accumulation, in vivo, in response to activated macrophages.99
[4Fe–4S] WhiB3 was shown to react with NO, leading to the
suggestion that WhiB3 acts as a sensor of O2 and NO to
control expression of genes involved in intermediary metab-
olism.100 This provided a key connection to the well documen-
ted accumulation in M. tuberculosis of tri-acylglycerol (which is
also present in the sputum of tuberculosis patients) in
response to hypoxia and NO exposure.101 M. tuberculosis
WhiB1 is essential for cell viability and has been shown to
bind specific DNA sequences following cluster nitrosylation,102
and to bind the principal housekeeping Sigma factor of the
cell in a cluster-dependent manner.46
Native MS revealed that, like NsrR, the addition of NO led
to the loss of the [4Fe–4S] WhiD peak. However, the
decay behaviour was very different to that observed for NsrR,
with the [4Fe–4S] WhiD peak decaying gradually throughout
the titration, being lost entirely only at [NO] : [4Fe–4S] ≥ 10;
consistent with earlier spectroscopic studies.86 Cluster
nitrosylation peaks were observed at +30 Da, +60 Da in WhiD
spectra and persisted over a broad range of NO concentrations
until the [4Fe–4S] WhiD peak decayed away. Isotope shift
analysis (natural abundance vs. 57Fe/34S enriched cluster)
revealed a mass difference of +12 Da, consistent with their
assignment as [4Fe–4S](NO) and [4Fe–4S](NO)2, respectively
(Fig. 6b).47 A further peak at +120 Da, corresponding to a tetra-
nitrosylated cluster, [4Fe–4S](NO)4, was also observed.
47,94 At
higher ratios of NO, RBS-type species were detected, see
Fig. 6c.47
Native MS has also been used to investigate the interaction
of Wbl proteins with the principle Sigma factor, an important
part of the cellular transcriptional machinery. Native MS
studies of both WhiB1 from M. tuberculosis and WhiD from
S. venezuelae have demonstrated 1 : 1 complex formation that
is dependent on the [4Fe–4S] cluster. These complexes were
either insensitive (WhiB1) or less sensitive (WhiD) to O2, but
reacted rapidly with NO, leading to dissociation of the
complex,46,103 supporting the idea that these proteins function
in sensing NO.
5. Conclusions
Native MS is a powerful methodology that can yield unpre-
cedented detail of the chemistry taking place at the active sites
of proteins, and in doing so provides unusually clear insight
into protein function. The work highlighted here demonstrates
the application of native MS in studies of more fragile (relative
to ferredoxins) Fe–S proteins, and the feasibility of time-
resolved native MS studies of reactions of Fe–S cluster cofac-
tors within a protein framework. Isotope substitution data,
from 34S-, 57Fe- or 34S/57Fe-substituted forms of Fe–S proteins,
are crucial for providing and unambiguous confirmation of
peak assignments for cluster conversion intermediates and
products, allowing differentiation between them and naturally
occurring background adducts.44,47,48,104,105 The wealth of
mechanistic data obtainable from native MS suggests that it is
likely to find broad application in studies of wider range of
protein cofactors systems involving interactions/reactions that
result in changes in mass.
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